cerbomed GmbH

Cerbomed GmbH is an innovative medical device company located in Erlangen, Germany, that focuses on neuromodulation. The company, founded in 2005, focuses on transcutaneous Vagus Nerve Stimulation (t-VNS®), which may offer an attractive therapy option for patients with hard-to-treat neurological and psychiatric illnesses.

In 2010 cerbomed received the European clearance (CE mark) for the transcutaneous Vagus Nerve Stimulation for the treatment of epilepsies and depression, in 2012 for the treatment of pain. Currently two clinical studies are carried out regarding the effectiveness of t-VNS in patients with drug-resistant epilepsy and chronic migraine.

In September 2012 cerbomed entered into a strategic partnership with Cyberonics, Inc., the global market leader in vagus nerve stimulation.

The therapy device NEMOS® for the treatment of epilepsies is available in Germany, Austria and Italy.

NEMOS® is not cleared or approved for use in the U.S.

Contact

Do you have questions regarding NEMOS® and t-VNS® therapy? Please get in touch with us.



Please note: NEMOS® is not cleared or approved for use in the U.S.